September 5, 2023
September is National Preparedness Month In a world that is constantly evolving and where the frequency and intensity of emergencies is increasing, it's crucial to be prepared for the unexpected. National Preparedness [...]
June 16, 2023
On February 2, 2023, the Health Resources and Services Administration (HRSA) published Program Assistance Letter (PAL) 2023-01, Calendar Year 2024 Requirements for Federal Tort Claims Act (FTCA) Coverage for Health Centers and [...]
June 9, 2023
On May 9, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.” [...]
May 31, 2023
Yesterday, the American Health Law Association, in conjunction with the National Asian Pacific American Bar Association, released their latest podcast “Career Journeys in Health Law: Insights from Four Asian American Attorneys.” FTLF [...]
April 11, 2023
This week, FTLF attorneys Phillip A. Escoriaza, Rosie Dawn Griffin, and Scott S. Sheffler will speak at the National Grant Management Association’s (NGMA) 2023 Annual Grants Training in Washington, DC. The firm’s [...]
January 17, 2023
On December 27, 2022, the Department of Health and Human Services (HHS) issued a guidance document relating to the obligations of Federally qualified health centers (FQHCs) to issue a good faith estimate [...]
January 10, 2023
In December, the Office for Civil Rights (OCR), in coordination with the Substance Abuse and Mental Health Services Administration (SAMSA), issued a Notice of Proposed Rule Making (NPRM) that would modify the [...]
December 22, 2022
On December 1, the Office for Civil Rights (OCR) issued guidance on the use of online tracking technologies by HIPAA covered entities and business associates. Health care providers, including hospital and health [...]
September 19, 2022
A recent Determination of Coverage provides that, under specific circumstances, the dispensing and prescribing of Naloxone to non-health center patients is protected by the Federal Tort Claims Act (FTCA) program. On August [...]
July 22, 2022
The Department of Health and Human Services Office of Inspector General (OIG) issued a Special Fraud Alert[1] (Alert) on July 20, 2022, to highlight areas of concern that OIG has identified in [...]